WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (34)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Scheller, M.
Right arrow Articles by Forman, S. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Scheller, M.
Right arrow Articles by Forman, S. A.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*PICROTOXIN

 Previous Article  |  Next Article 

The Journal of Neuroscience, October 1, 2002, 22(19):8411-8421

Coupled and Uncoupled Gating and Desensitization Effects by Pore Domain Mutations in GABAA Receptors

Michaela Scheller1 and Stuart A. Forman2

1 Klinik fuer Anaesthesiologie der Technischen Universitaet Muenchen, Klinikum rechts der Isar, D-81675 Munich, Germany, and 2 Department of Anesthesia and Critical Care, Massachusetts General Hospital, Boston, Massachusetts 02114

GABAA receptors are allosteric ligand-gated ion channels. Agonist-induced gating and desensitization have been proposed to be coupled via pore domain structures. Mutations at two alpha 1 subunit pore-domain (transmembrane domain 2) residues enhance GABA sensitivity, leucine-to-threonine at position 264 (9'), and serine-to-isoleucine at position 270 (15'). We investigated the role of these residues in gating, desensitization, and deactivation of alpha 1beta 2gamma 2L GABAA receptors using rapid GABA concentration jumps and patch-clamp electrophysiology. GABA EC50 values for alpha 1(L264T)beta 2gamma 2L and alpha 1(S270I)beta 2gamma 2L currents were, respectively, ~80-fold and 13-fold lower than the wild-type EC50. Unlike wild type, both mutant receptors displayed significant picrotoxin-sensitive currents in the absence of GABA, indicating that they enhance gating efficacy. Both mutants displayed current activation rates that matched wild type at 1 µM GABA and above. Desensitization of wild-type and alpha 1(S270I)beta 2gamma 2L currents displayed indistinguishable rates and amplitudes, whereas alpha 1(L264T)beta 2gamma 2L currents desensitized extremely slowly. Deactivation of wild-type currents displayed two rates and slowed after partial desensitization, whereas currents from both mutants deactivated slowly with single rate constants that were unaffected by desensitization. These results indicate that both alpha 1(L264T) and alpha 1(S270I) mutations increase the gating efficacy of receptors by slowing channel closing, which accounts for nearly all of the similar changes that they produce in macrocurrent dynamics. Because the alpha 1(S270I) mutation uncouples its gating effects from those on rapid desensitization, these two processes are necessarily associated with movements of distinct receptor structures (gates). The effects of the alpha 1(L264T) mutation suggest that the conserved leucines may play a role in gating-desensitization coupling.

Key words: GABA receptor; acetylcholine receptor; ion channel; gating; desensitization; pore; electrophysiology


Copyright © 2002 Society for Neuroscience  0270-6474/02/22198411-11$05.00/0


This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
D. Stewart, R. Desai, Q. Cheng, A. Liu, and S. A. Forman
Tryptophan Mutations at Azi-Etomidate Photo-Incorporation Sites on {alpha}1 or {beta}2 Subunits Enhance GABAA Receptor Gating and Reduce Etomidate Modulation
Mol. Pharmacol., December 1, 2008; 74(6): 1687 - 1695.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
X.-Q. Hu and R. W. Peoples
Arginine 246 of the Pretransmembrane Domain 1 Region Alters 2,2,2-Trichloroethanol Action in the 5-Hydroxytryptamine3A Receptor
J. Pharmacol. Exp. Ther., March 1, 2008; 324(3): 1011 - 1018.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
K. Solt, D. Ruesch, S. A. Forman, P. A. Davies, and D. E. Raines
Differential Effects of Serotonin and Dopamine on Human 5-HT3A Receptor Kinetics: Interpretation within an Allosteric Kinetic Model
J. Neurosci., November 28, 2007; 27(48): 13151 - 13160.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
M. T. Bianchi, E. J. Botzolakis, K. F. Haas, J. L. Fisher, and R. L. Macdonald
Microscopic kinetic determinants of macroscopic currents: insights from coupling and uncoupling of GABAA receptor desensitization and deactivation
J. Physiol., November 1, 2007; 584(3): 769 - 787.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
A. Keramidas, T. L. Kash, and N. L. Harrison
The pre-M1 segment of the {alpha}1 subunit is a transduction element in the activation of the GABAA receptor
J. Physiol., August 15, 2006; 575(1): 11 - 22.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
B. L. Jones, P. J. Whiting, and L. P. Henderson
Mechanisms of anabolic androgenic steroid inhibition of mammalian {varepsilon}-subunit-containing GABAA receptors
J. Physiol., June 15, 2006; 573(3): 571 - 593.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
D. A. Wagner, M. P. Goldschen-Ohm, T. G. Hales, and M. V. Jones
Kinetics and Spontaneous Open Probability Conferred by the {epsilon} Subunit of the GABAA Receptor
J. Neurosci., November 9, 2005; 25(45): 10462 - 10468.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
X.-Q. Hu and D. M Lovinger
Role of aspartate 298 in mouse 5-HT3A receptor gating and modulation by extracellular Ca2+
J. Physiol., October 15, 2005; 568(2): 381 - 396.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
H.-J. Feng and R. L. Macdonald
Multiple Actions of Propofol on {alpha}{beta}{gamma} and {alpha}{beta}{delta} GABAA Receptors
Mol. Pharmacol., December 1, 2004; 66(6): 1517 - 1524.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
R.-Q. Huang, Z. Chen, and G. H. Dillon
Molecular Basis for Modulation of Recombinant {alpha}1{beta}2{gamma}2 GABAA Receptors by Protons
J Neurophysiol, August 1, 2004; 92(2): 883 - 894.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
M. J. Gallagher, L. Song, F. Arain, and R. L. Macdonald
The Juvenile Myoclonic Epilepsy GABAA Receptor {alpha}1 Subunit Mutation A322D Produces Asymmetrical, Subunit Position-Dependent Reduction of Heterozygous Receptor Currents and {alpha}1 Subunit Protein Expression
J. Neurosci., June 16, 2004; 24(24): 5570 - 5578.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
M. Mortensen, U. Kristiansen, B. Ebert, B. Frolund, P. Krogsgaard-Larsen, and T. G. Smart
Activation of single heteromeric GABAA receptor ion channels by full and partial agonists
J. Physiol., June 1, 2004; 557(2): 389 - 413.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Miko, E. Werby, H. Sun, J. Healey, and L. Zhang
A TM2 Residue in the {beta}1 Subunit Determines Spontaneous Opening of Homomeric and Heteromeric {gamma}-Aminobutyric Acid-gated Ion Channels
J. Biol. Chem., May 28, 2004; 279(22): 22833 - 22840.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Rusch, H. Zhong, and S. A. Forman
Gating Allosterism at a Single Class of Etomidate Sites on {alpha}1{beta}2{gamma}2L GABAA Receptors Accounts for Both Direct Activation and Agonist Modulation
J. Biol. Chem., May 14, 2004; 279(20): 20982 - 20992.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
A. C. Hall, K. C. Rowan, R. J. N. Stevens, J. C. Kelley, and N. L. Harrison
The Effects of Isoflurane on Desensitized Wild-Type and {alpha}1(S270H) {gamma}-Aminobutyric Acid Type A Receptors
Anesth. Analg., May 1, 2004; 98(5): 1297 - 1304.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. N. Goren, D. C. Reeves, and M. H. Akabas
Loose Protein Packing around the Extracellular Half of the GABAA Receptor {beta}1 Subunit M2 Channel-lining Segment
J. Biol. Chem., March 19, 2004; 279(12): 11198 - 11205.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
D. A. Wagner, C. Czajkowski, and M. V. Jones
An Arginine Involved in GABA Binding and Unbinding But Not Gating of the GABAA Receptor
J. Neurosci., March 17, 2004; 24(11): 2733 - 2741.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. Bali and M. H. Akabas
Defining the Propofol Binding Site Location on the GABAA Receptor
Mol. Pharmacol., January 1, 2004; 65(1): 68 - 76.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Ren, Y. Honse, and R. W. Peoples
A Site of Alcohol Action in the Fourth Membrane-associated Domain of the N-Methyl-D-aspartate Receptor
J. Biol. Chem., December 5, 2003; 278(49): 48815 - 48820.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
J. W. Mozrzymas, E. D. Zarmowska, M. Pytel, and K. Mercik
Modulation of GABAA Receptors by Hydrogen Ions Reveals Synaptic GABA Transient and a Crucial Role of the Desensitization Process
J. Neurosci., September 3, 2003; 23(22): 7981 - 7992.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
J. M. Sonner, J. F. Antognini, R. C. Dutton, P. Flood, A. T. Gray, R. A. Harris, G. E. Homanics, J. Kendig, B. Orser, D. E. Raines, et al.
Inhaled Anesthetics and Immobility: Mechanisms, Mysteries, and Minimum Alveolar Anesthetic Concentration
Anesth. Analg., September 1, 2003; 97(3): 718 - 740.
[Abstract] [Full Text] [PDF]



-
-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2009 by Society for Neuroscience ONLINE ISSN: 1529-2401
-